Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Quantification of progressive retinal thinning in patients with fibromyalgia syndrome over a period of 5 years

  • Satue, M.
  • Vicente, M.J.
  • Perez-Velilla, J.
  • Tello, A.
  • Vilades, E.
  • Orduna, E.
  • Cordon, B.
  • Garcia-Campayo, J.
  • Puebla-Guedea, M.
  • Garcia-Martin, E.
Purpose: To quantify changes in visual function parameters and the macular neuroretina of patients with Fibromyalgia (FM) over 5 years, compared with controls. Methods: Eighty patients with FM and 38 healthy subjects were included in a prospective observational study and underwent visual acuity (VA) evaluation with ETDRS chart, contrast sensitivity vision (CSV) with CSV 1000E test, and retinal evaluation using Spectralis Optical coherence tomography (OCT). All subjects were re-evaluated after 5 years to quantify changes in visual function parameters and ganglion cell layer (GCL) and retinal nerve fiber layer (RNFL) thickness. The relationship between progressive structural, functional and disease severity changes was analysed. Additionally, patients were classified into three different groups to analyse progression depending on the disease phenotype. Results: When compared with controls, patients with FM presented worse low contrast VA (p=0.024), and low frequency CSV (p=0.004) after a 5-year follow up. A progressive decrease affecting the GCL thickness (nasal 1, p=0.004; temporal 1, p<0.001; inferior 1, p=0.001) and the RNFL (nasal 1 and 2, p<0.001; superior 1, p<0.001; and inferior 1, p=0.002) was observed in patients over the monitoring time. Changes affecting the GCL were correlated with progression in disease severity scores (EQ-5D, r=0.560, p<0.001; FIQ, r=-0.470, p=0.003). Correlations between structural changes and disease severity scores were only observed in the atypical and biologic phenotypes. Conclusions: Progressive visual dysfunction and retinal neurodegeneration was detected in FM patients. The evaluation of visual parameters and GCL/ RNFL thickness using SD-OCT can be useful to monitor FM progression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Progressive visual dysfunction and retinal neurodegeneration in patients with fibromyalgia

  • Garcia-Martín, E.
  • Vicente Altabás, M. J.
  • Vilades Palomar, E.
  • Orduna Hospital, E.
  • Cordón Ciordia, B.
  • García-Campayo, J.
  • Puebla-Guedea, M.
  • Satue Palacian, M.
Background Pathophysiology of fibromyalgia is still not well known. There are certain theories than point out a possible neurodegeneration component. Objectives To evaluate variations in visual function parameters and in the macular ganglion cell layer (CGR) of patients with Fibromyalgia (FM) over a period of 5 years, and compare these results with controls. Method 85 patients with FM and 41 healthy subjects underwent a complete ophthalmic evaluation, including assessment of visual acuity (VA) with ETDRS, contrast sensitivity vision (CSV) with Pelli Robson, color vision with Farnsworth and Lanthony D15 tests and retinal evaluation using Cirrus HD-OCT 3000 (Carl Zeiss, California). All subjects were re-evaluated after 5 years. It was also analysed the association between progressive structural, functional and disease severity changes. Furthermore, patients were classified into three groups (1, atypical; 2, depressive; 3, biologic). Results Progressive changes were detected in visual function parameters and CGR thickness in FM patients after 5 years. Patients with FM presented worse low contrast VA (p = 0.022), color discrimination (Lanthony's C index, p = 0.006) and decreased CGR thickness (nasal inferior, p < 0.001) over the follow up time, compared with controls. Changes in color vision were associated with CGR thinning, but no correlations with disease severity were observed. Conclusions It has been noticed progressive visual dysfunction and CGR loss in patients suffering from FM. The analysis of visual function parameters and CGR thickness using Cirrus OCT could be of value to control FM disease. Contexto La fisiopatología de la fibromialgia todavía no se conoce bien. Existen ciertas teorías que señalan un posible componente neurodegenerativo. Objetivos Evaluar variaciones en los parámetros de la función visual y en la capa de células ganglionares (CCG) maculares de pacientes con fibromialgia (FM) durante un período de 5 años, y comparar estos resultados con los de controles sanos. Método Ochenta y cinco pacientes con FM y 41 sujetos sanos se sometieron a una evaluación oftálmica completa, incluyendo evaluación de agudeza visual (AV) con ETDRS, visión de sensibilidad al contraste (VSC) con Pelli Robson, visión de colores con las pruebas Farnsworth y Lanthony D15 y evaluación de retina con el tomógrafo de coherecia óptica Cirrus HD-OCT 3000 (Carl Zeiss, California). Todos los sujetos fueron reevaluados 5 años después. También se analizó la asociación entre cambios progresivos estructurales, funcionales y de gravedad de la enfermedad. Además, los pacientes se clasificaron en 3 grupos (1: atípicos; 2: depresivos; 3: biológicos). Resultados Se detectaron cambios progresivos en los parámetros de la función visual y el espesor de la CCG en pacientes con FM después de 5 años. Los pacientes con FM presentaron peor AV de bajo contraste (p = 0,022), discriminación de color (índice C de Lanthony, p = 0,006) y disminución del grosor de la CCG (nasal inferior, p < 0,001) durante el tiempo de seguimiento, en comparación con los controles. Los cambios en la visión del color se asociaron con el adelgazamiento de la CCG, pero no se observaron correlaciones con la gravedad de la enfermedad. Conclusiones Se ha observado disfunción visual progresiva y pérdida de CCG en pacientes que padecen FM. El análisis de los parámetros de la función visual y el espesor de la CCG mediante Cirrus OCT podría ser valioso para controlar la FM.